The end in sight to abort the common Cold Virus

An important news release was made in the world press yesterday November 2 that a breakthrough had been made in identifying how the Cold Virus works in infecting a person.

One of these announcements is copied below:
'Currently, medical text books state that once a virus breaks into a cell, that cell can be written-off as infected, a lost cause. Not so, say the Cambridge crew.

They've discovered that the body's natural antibodies, which attack viruses in the bloodstream and fluids surrounding cells, actually affix themselves to the viruses and piggyback into the cells being attacked.

Once inside the cell, the antibodies' presence triggers a reaction and prompts a protein called TRIM21 to unleash a powerful virus-eating mechanism which can dispatch with the offending bug in a matter of hours.

Up until now, immunologists believed antibodies only functioned outside our bodies' cells. The revelation opens up the possibility of a whole new type of drug to treat the cold virus, and even more harmful viruses like noravirus and rotavirus, which sicken thousands and even kill many children in the developing world every year.'



I have been using and prescribing Ferr Phos 6x dose 3 tablets taken every 3 hours to patients to stop an oncoming cold and I could not help feeling that Ferr Phos which is known to increase the oxygen carrying capacity of the blood, may also be working in a similar manner in the cell to prevent the virus from propagating. I can personally vouch for the fact that this remedy will abort the Cold Virus and it is best taken as early as possible when the first signs of an oncoming cold with sneezing and coryza are felt.

It is my hope that research will be made on this phenomenon by laboratories that have the facilities to do so using Ferr Phos 6x on a double blind basis and prove to Big Pharma that Homeopathy had the answer to overcome the Cold Virus long before they did. It is reported that suitable drugs may be available in a few years and this is estimated to be at least 3 years into the future before a suitable drug is commercially available.